Daiichi Life Group (TSE:8750) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:8750 Daiichi Life Group Inc TSE:8750
71 GF Score
Price 円1,728.00
GF Value 円1,168.05
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Daiichi Life Group Research & Development?

Daiichi Life Group TSE:8750 -4.64% 71 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:8750 with a GF Score™ of 71/100 and a GF Value™ of 円1,168.05 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Daiichi Life Group's Research & Development for the three months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Daiichi Life Group  (TSE:8750) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Daiichi Life Group Research & Development Related Terms

Daiichi Life Group Research & Development Historical Data

* Premium members only.

The historical data trend for Daiichi Life Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daiichi Life Group Research & Development Chart

Daiichi Life Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Daiichi Life Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:8750
71GF Score
Daiichi Life Group Inc TSE:8750
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Daiichi Life Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Daiichi Life Group (TSE:8750) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Daiichi Life Group and its competitors.
Is Daiichi Life Group's Research & Development too high?
Daiichi Life Group's current Research & Development is 円0 Mil. Overall, Daiichi Life Group has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Daiichi Life Group's Research & Development compare to AFL and MET?
Daiichi Life Group's Research & Development of 円0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Daiichi Life Group and its competitors. Daiichi Life Group's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiichi Life Group stock overvalued right now?
Based on GuruFocus' analysis, Daiichi Life Group (TSE:8750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,168.05, compared to a current price of 円1,728.00 — trading 47.9% above its estimated fair value. The current Research & Development is 円0 Mil. Daiichi Life Group's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Daiichi Life Group (TSE:8750), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Daiichi Life Group (TSE:8750) Overvalued in 2026?

Based on GuruFocus' analysis, Daiichi Life Group stock appears to be overvalued. The current stock price of 円1,728.00 is trading 47.9% above its estimated GF Value™ of 円1,168.05. GuruFocus considers Daiichi Life Group to be Significantly Overvalued.

Key valuation signals for TSE:8750:

  • Research & Development: 円0 Mil
  • GF Value™: 円1,168.05 vs. price of 円1,728.00 (47.9% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the TSE:8750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daiichi Life Group Business Description

Address 13-1, Yurakucho 1-chome, Chiyoda-ku, Tokyo, JPN, 100-8411
Dai-ichi Life is Japan's second-largest life insurer (excluding the recently privatized Japan Post Insurance), commanding 11% of annualized net premiums. Unlike its largest domestic rivals—Nippon Life, Meiji Yasuda, and Sumitomo Life—which remain mutually owned by policyholders, Dai-ichi Life demutualized and listed on the Tokyo Stock Exchange in 2010. The group's profit profile is geographically diversified: The main domestic life business contributes roughly 75% of profits, the overseas life business contributes about 22%, and the noninsurance business contributes about 4% of total profits.
71GF Score

Get the complete analysis for TSE:8750

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,728.00
Price
円1,168.05
GF Value